Recruiting
Phase 2

Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults with B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

Sponsor:

Alliance for Clinical Trials in Oncology

Code:

NCT05303792

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Vincristine

Dexamethasone

Inotuzumab Ozogamicin

Methotrexate

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information